Luo Zhou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Luo Zhou has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
Bo Xiao
Department of Neurology, Xiangya Hospital, Central South University, Changsha, China
14 shared publicationsPeihong Li
Department of Neurology, Xiangya Hospital Central South University Changsha Hunan China
12 shared publicationsZheng Xiao
Department of Pathology First Hospital of Changsha Changsha Hunan China
12 shared publicationsJiaxin Li
Department of Neurology, Xiangya Hospital Central South University Changsha Hunan China
9 shared publicationsDandan Sheng
Department of Neurology, Xiangya Hospital, Central South University, Changsha, China
7 shared publicationsWeiping Liu
Department of Neurology, Xiangya Hospital, Central South University, Changsha, China
5 shared publications
Latest Publications
- 10 July 2026
- Published by Springer Nature in Neurochemical Research
- Vol. 51 (4) , 212
Role of the miR-340-5p/IRF1/USP18 Axis in Neuroinflammation Associated with Epilepsy
Epilepsy is a prevalent neurological disorder, in which maladaptive neuroinflammation critically contributes to epileptogenesis. In this study, we identified a previously unrecognized signaling axis that regulates inflammatory responses and inflammatory cell death in experimental epilepsy. Integrated bioinformatic analyses of the GSE73878 and GSE18740 datasets, together with transcription factor and microRNA prediction databases, highlighted USP18 and its upstream regulators as key candidates. Functional and mechanistic validations were performed using lipopolysaccharide-stimulated BV2 microglia and pentylenetetrazole-induced mouse seizure models. Seizure severity and epileptic phenotypes were confirmed using the Racine scale assessments and EEG recordings. USP18 was markedly upregulated under epileptic conditions accompanied by increased pro-inflammatory cytokine release, apoptosis, and pyroptosis. Silencing USP18 attenuated neuroinflammation and reduced seizure severity. Mechanistically, interferon regulatory factor 1 (IRF1) was identified as a direct transcriptional activator of USP18, whereas miR-340-5p suppressed USP18 expression by targeting IRF1, thereby mitigating inflammatory signaling and neuronal injury. Collectively, these findings reveal a novel regulatory pathway linking microRNA-mediated control, interferon-responsive transcription, and inflammatory effector mechanisms in epilepsy, and suggest that targeting the miR-340-5p/IRF1/USP18 axis may represent a promising disease-modifying therapeutic strategy.
- 10 July 2026
- Published by Springer Nature in Neurochemical Research
- Vol. 51 (4) , 212
Role of the miR-340-5p/IRF1/USP18 Axis in Neuroinflammation Associated with Epilepsy
Epilepsy is a prevalent neurological disorder, in which maladaptive neuroinflammation critically contributes to epileptogenesis. In this study, we identified a previously unrecognized signaling axis that regulates inflammatory responses and inflammatory cell death in experimental epilepsy. Integrated bioinformatic analyses of the GSE73878 and GSE18740 datasets, together with transcription factor and microRNA prediction databases, highlighted USP18 and its upstream regulators as key candidates. Functional and mechanistic validations were performed using lipopolysaccharide-stimulated BV2 microglia and pentylenetetrazole-induced mouse seizure models. Seizure severity and epileptic phenotypes were confirmed using the Racine scale assessments and EEG recordings. USP18 was markedly upregulated under epileptic conditions accompanied by increased pro-inflammatory cytokine release, apoptosis, and pyroptosis. Silencing USP18 attenuated neuroinflammation and reduced seizure severity. Mechanistically, interferon regulatory factor 1 (IRF1) was identified as a direct transcriptional activator of USP18, whereas miR-340-5p suppressed USP18 expression by targeting IRF1, thereby mitigating inflammatory signaling and neuronal injury. Collectively, these findings reveal a novel regulatory pathway linking microRNA-mediated control, interferon-responsive transcription, and inflammatory effector mechanisms in epilepsy, and suggest that targeting the miR-340-5p/IRF1/USP18 axis may represent a promising disease-modifying therapeutic strategy.
- 3 January 2025
- Published by Wiley in American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
- Vol. 198 (4) , e33021
Appraising the Effects of Gut Microbiota on Insomnia Risk Through Genetic Causal Analysis
BackgroundInsomnia is a common neurological disorder that exhibits connections with the gut microbiota; however, the exact causal relationship remains unclear. MethodsWe conducted a Mendelian randomization (MR) study to systematically evaluate the causal effects of genus‐level gut microbiota on insomnia risk in individuals of European ancestry. Summary‐level datasets on gut microbiota were sourced from the genome‐wide association study (GWAS) of MiBioGen, while datasets on insomnia were obtained from the GWAS of Neale Lab and FinnGen. The primary analytical approach used was the inverse‐variance weighted (IVW) method, supplemented by MR‐Egger, maximum likelihood, MR‐robust adjusted profile score, and weighted median. Sensitivity analyses were conducted to ensure robustness. ResultsThe microbial taxa Enterorhabdus, Family XIII AD3011 group, Paraprevotella, and Lachnospiraceae UCG004 were associated with an increased risk of insomnia, whereas Coprococcus1, Coprobacter, Desulfovibrio, Flavonifractor, Olsenella, Odoribacter, and Oscillibacter were linked to a decreased risk. Regarding the insomnia phenotype characterized by trouble falling asleep, the microbial taxon Eisenbergiella was correlated with an increased risk, while Haemophilus and the Eubacterium brachy group were associated with a reduced risk. Furthermore, for the insomnia phenotype characterized by waking too early, the microbial taxa Family XIII UCG001, Lachnospiraceae FCS020 group, and Olsenella were linked to an increased risk, whereas the Eubacterium brachy group and Victivallis were associated with a lower risk. The results remained robust across all sensitivity analyses. ConclusionOur MR study identified multiple genus‐level gut microbial taxa that may exhibit potential causal effects on insomnia from a genetic perspective. These findings provide evidence supporting the theory of the microbiota‐gut‐brain axis and offer new insights into potential prevention and therapeutic targets for insomnia.
- 3 January 2025
- Published by Wiley in American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
- Vol. 198 (4) , e33021
Appraising the Effects of Gut Microbiota on Insomnia Risk Through Genetic Causal Analysis
BackgroundInsomnia is a common neurological disorder that exhibits connections with the gut microbiota; however, the exact causal relationship remains unclear. MethodsWe conducted a Mendelian randomization (MR) study to systematically evaluate the causal effects of genus‐level gut microbiota on insomnia risk in individuals of European ancestry. Summary‐level datasets on gut microbiota were sourced from the genome‐wide association study (GWAS) of MiBioGen, while datasets on insomnia were obtained from the GWAS of Neale Lab and FinnGen. The primary analytical approach used was the inverse‐variance weighted (IVW) method, supplemented by MR‐Egger, maximum likelihood, MR‐robust adjusted profile score, and weighted median. Sensitivity analyses were conducted to ensure robustness. ResultsThe microbial taxa Enterorhabdus, Family XIII AD3011 group, Paraprevotella, and Lachnospiraceae UCG004 were associated with an increased risk of insomnia, whereas Coprococcus1, Coprobacter, Desulfovibrio, Flavonifractor, Olsenella, Odoribacter, and Oscillibacter were linked to a decreased risk. Regarding the insomnia phenotype characterized by trouble falling asleep, the microbial taxon Eisenbergiella was correlated with an increased risk, while Haemophilus and the Eubacterium brachy group were associated with a reduced risk. Furthermore, for the insomnia phenotype characterized by waking too early, the microbial taxa Family XIII UCG001, Lachnospiraceae FCS020 group, and Olsenella were linked to an increased risk, whereas the Eubacterium brachy group and Victivallis were associated with a lower risk. The results remained robust across all sensitivity analyses. ConclusionOur MR study identified multiple genus‐level gut microbial taxa that may exhibit potential causal effects on insomnia from a genetic perspective. These findings provide evidence supporting the theory of the microbiota‐gut‐brain axis and offer new insights into potential prevention and therapeutic targets for insomnia.
- Open Access
- 21 December 2024
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 34 (2) , 108212
Gut microbiota and hemorrhagic stroke: Emerging insights and future perspectives
- 21 December 2024
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 34 (2) , 108212
Open AccessGut microbiota and hemorrhagic stroke: Emerging insights and future perspectives
- 26 November 2024
- Published by Springer Nature in Immunogenetics
- Vol. 77 (1) , 1-13
Exploring the therapeutic potential of interleukin-6 receptor blockade in autoimmune diseases using drug target mendelian randomization
The blockade of the interleukin 6 receptor (IL-6R) demonstrates significant potential in various autoimmune diseases (ADs); however, the underlying therape
- 26 November 2024
- Published by Springer Nature in Immunogenetics
- Vol. 77 (1) , 1-13
Exploring the therapeutic potential of interleukin-6 receptor blockade in autoimmune diseases using drug target mendelian randomization
The blockade of the interleukin 6 receptor (IL-6R) demonstrates significant potential in various autoimmune diseases (ADs); however, the underlying therape
- Open Access
- 9 November 2024
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 34 (1) , 108131
Investigating the role of gut microbiota in hemorrhagic stroke: Evidence from causal analysis
- 9 November 2024
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 34 (1) , 108131
Open AccessInvestigating the role of gut microbiota in hemorrhagic stroke: Evidence from causal analysis
- Open Access
- 3 July 2024
- Published by Springer Nature in Human Genomics
- Vol. 18 (1) , 1-12
Association of lipid-lowering drugs with risk of sarcopenia: a drug target mendelian randomization study and meta-analysis
Background: Lipid-lowering drugs are widely used among the elderly, with some studies suggesting links to muscle-related symptoms. However, the causality remains uncertain. Methods: Using the Mendelian randomization (MR) approach, we assessed the causal effects of genetically proxied reduced low-density lipoprotein cholesterol (LDL-C) through inhibitions of hydroxy-methyl-glutaryl-CoA reductase (HMGCR), proprotein convertase subtilisin/kexin type 9 (PCSK9), and Niemann-Pick C1-like 1 (NPC1L1) on sarcopenia-related traits, including low hand grip strength, appendicular lean mass, and usual walking pace. A meta-analysis was conducted to combine the causal estimates from different consortiums. Results: Using LDL-C pooled data predominantly from UK Biobank, genetically proxied inhibition of HMGCR was associated with higher appendicular lean mass (beta = 0.087, P = 7.56 × 10− 5) and slower walking pace (OR = 0.918, P = 6.06 × 10− 9). In contrast, inhibition of PCSK9 may reduce appendicular lean mass (beta = -0.050, P = 1.40 × 10− 3), while inhibition of NPC1L1 showed no causal impact on sarcopenia-related traits. These results were validated using LDL-C data from Global Lipids Genetics Consortium, indicating that HMGCR inhibition may increase appendicular lean mass (beta = 0.066, P = 2.17 × 10− 3) and decelerate walking pace (OR = 0.932, P = 1.43 × 10− 6), whereas PCSK9 inhibition could decrease appendicular lean mass (beta = -0.048, P = 1.69 × 10− 6). Meta-analysis further supported the robustness of these causal associations. Conclusions: Genetically proxied HMGCR inhibition may increase muscle mass but compromise muscle function, PCSK9 inhibition could result in reduced muscle mass, while NPC1L1 inhibition is not associated with sarcopenia-related traits and this class of drugs may serve as viable alternatives to sarcopenia individuals or those at an elevated risk.
- 3 July 2024
- Published by Springer Nature in Human Genomics
- Vol. 18 (1) , 1-12
Open AccessAssociation of lipid-lowering drugs with risk of sarcopenia: a drug target mendelian randomization study and meta-analysis
Background: Lipid-lowering drugs are widely used among the elderly, with some studies suggesting links to muscle-related symptoms. However, the causality remains uncertain. Methods: Using the Mendelian randomization (MR) approach, we assessed the causal effects of genetically proxied reduced low-density lipoprotein cholesterol (LDL-C) through inhibitions of hydroxy-methyl-glutaryl-CoA reductase (HMGCR), proprotein convertase subtilisin/kexin type 9 (PCSK9), and Niemann-Pick C1-like 1 (NPC1L1) on sarcopenia-related traits, including low hand grip strength, appendicular lean mass, and usual walking pace. A meta-analysis was conducted to combine the causal estimates from different consortiums. Results: Using LDL-C pooled data predominantly from UK Biobank, genetically proxied inhibition of HMGCR was associated with higher appendicular lean mass (beta = 0.087, P = 7.56 × 10− 5) and slower walking pace (OR = 0.918, P = 6.06 × 10− 9). In contrast, inhibition of PCSK9 may reduce appendicular lean mass (beta = -0.050, P = 1.40 × 10− 3), while inhibition of NPC1L1 showed no causal impact on sarcopenia-related traits. These results were validated using LDL-C data from Global Lipids Genetics Consortium, indicating that HMGCR inhibition may increase appendicular lean mass (beta = 0.066, P = 2.17 × 10− 3) and decelerate walking pace (OR = 0.932, P = 1.43 × 10− 6), whereas PCSK9 inhibition could decrease appendicular lean mass (beta = -0.048, P = 1.69 × 10− 6). Meta-analysis further supported the robustness of these causal associations. Conclusions: Genetically proxied HMGCR inhibition may increase muscle mass but compromise muscle function, PCSK9 inhibition could result in reduced muscle mass, while NPC1L1 inhibition is not associated with sarcopenia-related traits and this class of drugs may serve as viable alternatives to sarcopenia individuals or those at an elevated risk.
- 4 June 2024
- Published by Wiley in European journal of pain
- Vol. 28 (9) , 1585-1595
Causal effects of sedentary behaviours on the risk of migraine: A univariable and multivariable Mendelian randomization study
Background: Migraine is a common and burdensome neurological disorder. The causal relationship between sedentary behaviours (SBs) and migraine remains instinct. We aimed to evaluate the roles of SBs including watching TV, using computer and driving in the risk of migraine.Methods: We conducted a univariable and multivariable Mendelian randomization (MR) study based on summary datasets of large genome‐wide association studies. The inverse variance weighted method was utilized as the primary analytical tool. Cochran's Q, MR‐Egger intercept test, MR pleiotropy residual sum and outlier and leave‐one‐out were conducted as sensitivity analysis. Additionally, we performed a meta‐analysis to combine the causal estimates.Results: In the discovery analysis, we identified causal associations between time spent watching TV and an increased risk of migraine (p = 0.015) and migraine without aura (MO) (p = 0.002). Such causalities with increasing risk of migraine (p = 0.005), and MO (p = 0.006) were further verified using summary datasets from another study in the replication analysis. There was no significant causal association found between time spent using computer, driving and migraine or its two subtypes. The meta‐analysis and multivariable MR analysis also strongly supported the causal relationships between time spent watching TV and an increased risk of migraine (p = 0.0003 and p = 0.034), as well as MO (p < 0.0001 and p = 0.0004), respectively. These findings were robust under all sensitivity analysis.Conclusions: Our study suggested that time spent watching TV may be causally associated with an increased risk of migraine, particularly MO. Large‐scale and well‐designed cohort studies may be warranted for further validation.Significance Statement: This study represents the first attempt to investigate whether a causal relationship exists between SBs and migraine. Utilizing MR analysis helps mitigate reverse causation bias and confounding factors commonly encountered in observational cohorts, thereby enhancing the robustness of derived causal associations. Our MR analysis revealed that time spent watching TV may serve as a potential risk factor for migraine, particularly MO.
- 4 June 2024
- Published by Wiley in European journal of pain
- Vol. 28 (9) , 1585-1595
Causal effects of sedentary behaviours on the risk of migraine: A univariable and multivariable Mendelian randomization study
Background: Migraine is a common and burdensome neurological disorder. The causal relationship between sedentary behaviours (SBs) and migraine remains instinct. We aimed to evaluate the roles of SBs including watching TV, using computer and driving in the risk of migraine.Methods: We conducted a univariable and multivariable Mendelian randomization (MR) study based on summary datasets of large genome‐wide association studies. The inverse variance weighted method was utilized as the primary analytical tool. Cochran's Q, MR‐Egger intercept test, MR pleiotropy residual sum and outlier and leave‐one‐out were conducted as sensitivity analysis. Additionally, we performed a meta‐analysis to combine the causal estimates.Results: In the discovery analysis, we identified causal associations between time spent watching TV and an increased risk of migraine (p = 0.015) and migraine without aura (MO) (p = 0.002). Such causalities with increasing risk of migraine (p = 0.005), and MO (p = 0.006) were further verified using summary datasets from another study in the replication analysis. There was no significant causal association found between time spent using computer, driving and migraine or its two subtypes. The meta‐analysis and multivariable MR analysis also strongly supported the causal relationships between time spent watching TV and an increased risk of migraine (p = 0.0003 and p = 0.034), as well as MO (p < 0.0001 and p = 0.0004), respectively. These findings were robust under all sensitivity analysis.Conclusions: Our study suggested that time spent watching TV may be causally associated with an increased risk of migraine, particularly MO. Large‐scale and well‐designed cohort studies may be warranted for further validation.Significance Statement: This study represents the first attempt to investigate whether a causal relationship exists between SBs and migraine. Utilizing MR analysis helps mitigate reverse causation bias and confounding factors commonly encountered in observational cohorts, thereby enhancing the robustness of derived causal associations. Our MR analysis revealed that time spent watching TV may serve as a potential risk factor for migraine, particularly MO.
- 22 March 2024
- Published by Elsevier in Journal of the American Medical Directors Association
- Vol. 25 (7) , 104968
A Mendelian Randomization Study Supports Bidirectional Causal Associations between Hearing Loss and Frailty
- 22 March 2024
- Published by Elsevier in Journal of the American Medical Directors Association
- Vol. 25 (7) , 104968
A Mendelian Randomization Study Supports Bidirectional Causal Associations between Hearing Loss and Frailty